Factors affecting the angiographic recanalization and early clinical improvement in middle cerebral artery territory infarction after thrombolysis

Arch Neurol. 2004 Nov;61(11):1682-6. doi: 10.1001/archneur.61.11.1682.

Abstract

Background: Factors affecting the angiographic recanalization (AR) and clinical improvement (CI) still remain unclear in patients receiving thrombolytic therapy.

Objectives: To elucidate factors related to AR and early CI in patients with middle cerebral artery (MCA) or internal carotid artery (ICA) occlusion.

Designs: Retrospective study.

Setting: Department of Neurology, Asan Medical Center, Seoul, South Korea.

Patients: We studied 42 patients who (1) underwent diffusion-weighted magnetic resonance (MR) imaging and MR angiography within 6 hours after onset, (2) had MCA territory infarction, (3) had nonvisualization of the MCA or the ICA on initial MR angiography, (4) were treated with thrombolytics, and (5) underwent follow-up MR imaging and MR angiography at day 2 or 3.

Results: Successful AR and CI were achieved in 31 and 16 patients, respectively. Angiographic recanalization was related to CI (P<.01), lower follow-up National Institutes of Health Stroke Scale scores (P<.05), the absence of a dominant ipsilateral posterior cerebral artery (P<.01) on initial MR angiography, and the sparing of the internal capsule on both initial (P<.05) and follow-up (P<.01) MR imaging. Clinical improvement was associated with the absence of ICA (vs MCA) flow signals (P<.05), the sparing of the internal capsule (P<.01), and marginally, with the infarct volume change (P = .06).

Conclusions: In patients with MCA or ICA occlusion, CI after thrombolysis is related to the AR and the sparing of the critical motor pathway. The presence of a dominant ipsilateral posterior cerebral artery may predict poor AR after thrombolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carotid Artery Diseases / drug therapy*
  • Cerebral Infarction / drug therapy*
  • Cerebral Infarction / therapy*
  • Cerebrovascular Circulation
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Health Status
  • Humans
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Magnetic Resonance Angiography*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Fibrinolytic Agents